San Francisco, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Global Home Infusion Therapy Market is expected to reach USD 31.9 billion by 2022. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings.
Browse Full Research Report With TOC On "Home Infusion Therapy Market Size, Report, 2022" at: http://www.radiantinsights.com/research/home-infusion-therapy-market-analysis-by-product-infusion-pumps-intravenous-sets-iv-cannulas-needleless-connectors-by-application-anti-infective-hydration-therapy-chemotherapy-enteral-nutrition-parenteral-nutrition-specialty-pharmaceuticals-and-segment-forecasts-to-2022
Further key findings from the study suggest:
- Needleless connectors are expected to witness lucrative growth over the forecast period. Growing demand for enhanced healthcare service provider safety has led to the rise in demand for needleless connectors.
- Anti-Infective dominated the market with a revenue share of over 25.0% in 2014. Home administration of anti-infective therapy is preferred by patients who have chronic infections that cannot be treated through oral agents. It is considered as the most user friendly home infusion therapy.
- North America accounted for more than 40% of the home infusion therapy market in 2014 on account of the presence of large geriatric population base. Presence of sophisticated healthcare infrastructure and favorable reimbursement plans laid out by regulatory bodies are also expected to make significant contributions towards market growth.
- Asia Pacific is expected to emerge as a high growth market over the forecast period. Presence of large unmet needs in the emerging economies such as China and India. Rising patient awareness levels regarding the benefits of home infusion therapies over the in-hospital infusion therapies is expected to further boost the growth of this region.
- Key players of home infusion therapy market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, CareFusion Corporation and Hospira Inc. Mergers and acquisitions and entering into strategic collaborations with healthcare providers are two key sustainability strategies adopted by these market participants.
Browse All Reports of This Category at: http://www.radiantinsights.com/catalog/medical-devices
Global Home Infusion Therapy Product Outlook (Revenue, USD Million, 2012 - 2022)
- Infusion pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Global Home Infusion Therapy Application Outlook (Revenue, USD Million, 2012 - 2022)
- Anti-Infective
- Hydration Therapy
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceutical
- Others
Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
- S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East and Africa (MEA)
- South Africa
Related Reports by Radiant Insights:
- Global Printed Batteries Market –
http://www.radiantinsights.com/research/global-printed-batteries-market-2014-2018
- Global Software Testing System Integrator Market –
http://www.radiantinsights.com/research/global-software-testing-system-integrator-market-2014-2018
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



